» Articles » PMID: 30813783

Locally Recurrent Chondrosarcoma of the Pelvis and Limbs Can Only Be Controlled by Wide Local Excision

Overview
Journal Bone Joint J
Date 2019 Mar 1
PMID 30813783
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: The purpose of this study was to investigate the potential for achieving local and systemic control after local recurrence of a chondrosarcoma of bone.

Patients And Methods: A total of 126 patients with local recurrence (LR) of chondrosarcoma (CS) of the pelvis or a limb bone were identified from a prospectively maintained database, between 1990 and 2015 at the Royal Orthopaedic Hospital, Birmingham, United Kingdom. There were 44 female patients (35%) and 82 male patients (65%) with a mean age at the time of LR of 56 years (13 to 96). The 126 patients represented 24.3% of the total number of patients with a primary CS (519) who had been treated during this period. Clinical data collected at the time of primary tumour and LR included the site (appendicular, extremity, or pelvis); primary and LR tumour size (in centimetres); type of operation at the time of primary or LR (limb-salvage or amputation); surgical margin achieved at resection of the primary tumour and the LR; grade of the primary tumour and the LR; gender; age; and oncological outcomes, including local recurrence-free survival and disease-specific survival. A minimum two years' follow-up and complete histopathology records were available for all patients included in the study.

Results: For patients without metastases prior to or at the time of local recurrence, the disease-specific survival after local recurrence was 62.5% and 45.5% at one and five years, respectively. After univariable analysis, significant factors predicting disease-specific survival were grade (p < 0.001) and surgical margin (p = 0.044). After multivariable analysis, grade, increasing age at the time of diagnosis of local recurrence, and a greater time interval from primary surgery to local recurrence were significant factors for disease-specific survival. A secondary local recurrence was seen in 26% of patients. Wide margins were a good predictor of local recurrence-free survival for subsequent recurrences after univariable analysis when compared with intralesional margins (p = 0.002) but marginal margins did not reach statistical significance when compared with intralesional margins (p = 0.084).

Conclusion: In cases of local recurrence of a chondrosarcoma of bone, we have shown that if the tumour is non-metastatic at re-staging, an increase in disease-specific survival and in local recurrence-free survival is achievable, but only by resection of the local recurrence with a wide margin. Cite this article: Bone Joint J 2019;101-B:266-271.

Citing Articles

The size of local recurrence influences outcomes in chondrosarcoma: Significant impact observed in grade 2 tumours.

Kask G, Laitinen M, Parry M, Kurisunkal V, Morris G, Stevenson J J Clin Orthop Trauma. 2025; 60:102866.

PMID: 39763638 PMC: 11700281. DOI: 10.1016/j.jcot.2024.102866.


UK guidelines for the management of bone sarcomas.

Gerrand C, Amary F, Anwar H, Brennan B, Dileo P, Kalkat M Br J Cancer. 2024; 132(1):32-48.

PMID: 39550489 PMC: 11723950. DOI: 10.1038/s41416-024-02868-4.


Enhancing Proton Radiosensitivity of Chondrosarcoma Using Nanoparticle-Based Drug Delivery Approaches: A Comparative Study of High- and Low-Energy Protons.

Tudor M, Popescu R, Irimescu I, Rzyanina A, Tarba N, Dinischiotu A Int J Mol Sci. 2024; 25(21).

PMID: 39519034 PMC: 11546389. DOI: 10.3390/ijms252111481.


The clinical outcomes and prognostic factors of dedifferentiated central chondrosarcoma in extremities.

Li Z, Liu W, Hao L, Zhang Q, Niu X J Orthop Surg Res. 2024; 19(1):621.

PMID: 39363319 PMC: 11448416. DOI: 10.1186/s13018-024-05098-9.


Unusual soft tissue metastases in a patient with chondrosarcoma: a case report.

Papalia G, Ariyaratne S, Vaiyapuri S, Botchu R, Kurisunkal V Int Cancer Conf J. 2024; 13(3):313-318.

PMID: 38962050 PMC: 11217250. DOI: 10.1007/s13691-024-00684-4.